InvestSMART

Wellnex Life Limited (ASX: WNX) - Announcements

- Current share price for WNX : $0.079

ASX company news and announcements for Wellnex Life Limited (WNX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Wellnex Life Limited (WNX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Wellnex Life Limited (WNX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Wellnex Life Limited (WNX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Appendix 3X - Vivenne Zhang 24 Mar 2025 9:31AM $0.570 $0.079 fallen by 86.14%
$6 Commencement of Trading on LSE AIM 24 Mar 2025 9:28AM $0.570 $0.079 fallen by 86.14%
$6 Admission Document for LSE AIM 21 Mar 2025 4:35PM $0.570 $0.079 fallen by 86.14%
$6 Application for quotation of securities - WNX 21 Mar 2025 4:27PM $0.570 $0.079 fallen by 86.14%
$6 Application for quotation of securities - WNX 21 Mar 2025 4:25PM $0.570 $0.079 fallen by 86.14%
$6 Pain Away Deferred Consideration Fully Satisfied 21 Mar 2025 4:11PM $0.570 $0.079 fallen by 86.14%
$6 Wellnex Publishes Admission Document to LSE AIM 19 Mar 2025 10:39AM $0.590 $0.079 fallen by 86.61%
$6 Trading Halt 18 Mar 2025 9:05AM $0.590 $0.079 fallen by 86.61%
$6 Cleansing Notice 14 Mar 2025 2:31PM $0.605 $0.079 fallen by 86.94%
$6 Application for quotation of securities - WNX 14 Mar 2025 2:09PM $0.600 $0.079 fallen by 86.83%
$6 Trading and UK IPO Update 14 Mar 2025 2:06PM $0.600 $0.079 fallen by 86.83%
$6 Appendix 3Y - Jeffrey Yeh Entitlement Offer 10 Mar 2025 10:32AM $0.610 $0.079 fallen by 87.05%
$6 Appendix 3Y - Zack Bozinovski Entitlement Offer 10 Mar 2025 10:30AM $0.610 $0.079 fallen by 87.05%
$6 Appendix 3Y - George Karafotias Entitlement Offer 10 Mar 2025 10:29AM $0.610 $0.079 fallen by 87.05%
$6 Change in substantial holding 7 Mar 2025 1:50PM $0.610 $0.079 fallen by 87.05%
$6 Application for quotation of securities - WNX 5 Mar 2025 12:32PM $0.625 $0.079 fallen by 87.36%
$6 Entitlement Offer Results 5 Mar 2025 12:31PM $0.625 $0.079 fallen by 87.36%
$6 Update - Proposed issue of securities - WNX 4 Mar 2025 11:41AM $0.630 $0.079 fallen by 87.46%
$6 Wellnex Life Releases Half Year Report 28 Feb 2025 5:49PM $0.640 $0.079 fallen by 87.66%
$6 Half Yearly Report and Accounts 28 Feb 2025 5:48PM $0.640 $0.079 fallen by 87.66%
$6 Update - Proposed issue of securities - WNX 28 Feb 2025 11:03AM $0.645 $0.079 fallen by 87.75%
$6 Director Participation in the Entitlement Offer 21 Feb 2025 10:25AM $0.660 $0.079 fallen by 88.03%
$6 Wellnex Secures $14.3m Conditional Binding Commitments 20 Feb 2025 8:57AM $0.640 $0.079 fallen by 87.66%
$6 Despatch of Entitlement Offer Booklet and Offer Open 17 Feb 2025 11:07AM $0.610 $0.079 fallen by 87.05%
$6 Ceasing to be a substantial holder 14 Feb 2025 5:20PM $0.640 $0.079 fallen by 87.66%

101 - 125 of 454 results

Page 5 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.